Posterior fossa primary intracranial extraosseous Ewing’s sarcoma: case report

Abstract

Background

Primary intracranial Ewing’s sarcoma (ES) is a type of primitive neuroectodermal tumour and is a rare malignant tumour in children and adolescents. The imaging features of ES overlap with other central nervous system embryonal tumours, making it difficult to pinpoint a specific diagnosis. We aim to explore the clinical, neuroimaging and differential diagnoses of this entity.

Case presentation

We describe a 6-month-old infant who presented with complaints of enlarging the head size and poor feeding. Imaging revealed a contrast-enhancing large solid-cystic mass lesion with internal calcification, focal bone erosion and haemorrhage in the posterior fossa. Histopathological examinations, immunohistochemistry, and molecular analysis confirmed ES.

Conclusions

The confirmative diagnosis of primary intracranial ES requires histological examination, immunohistochemical analysis, and genetic detection, along with radiological findings. Surgical excision followed by combined radiotherapy and chemotherapy is the treatment of choice.

Background

Primary intracranial Ewing sarcoma (ES)/Primitive neuroectodermal tumour (pPNET) is malignant small round cell neoplasms, that arise from bone and soft tissue, commonly seen in children and adolescents [1, 2]. Primary intracranial extraosseous ES is extremely rare, and only a few cases have been described [3,4,5,6,7]. Diagnosis of primary intracranial ES is made by the inclusion of radiological findings, histological examinations, and immunohistochemical and molecular genetic analysis. It must be differentiated from other CNS embryonal tumours as they have different treatments and prognoses. Radiological findings cannot differentiate PNET into its subtypes and often require genetic and immunohistochemical analysis such as MIC-2 antigen expression and detection of t(11;22)(q24;q12) translocation by fluorescent in situ hybridization (FISH) [7, 8]. The latest WHO 2021 classification of brain tumours lists ES as a mesenchymal non-meningothelial malignant tumour [9]. We aimed to highlight the rare malignant CNS entity with characteristic imaging features and aware the radiologist to keep the differential diagnosis.

Case presentation

A 6-month-old infant with an uneventful perinatal history, presented with complaints of increasing head circumference, irritability, poor feeding and vomiting for one month. On examinations, the patient was alert and irritable and vitals were within normal limits. Routine blood investigations were normal. Non-contrast CT scan of the head revealed a large solid-cystic mass lesion in the posterior fossa, with a solid portion of the lesion appearing hyperdense with multiple foci of calcifications (Fig. 1a). The cystic component appeared multiloculated with thick septations. Mass effect on the cerebellum and brainstem was present with moderate supratentorial hydrocephalus. The lesion was seen infiltrating the occipital bone causing permeative destruction, predominantly involving the inner table and diploic space (Fig. 1b). No extra-calvarial soft tissue was seen.

Fig. 1

NCCT shows a large solid-cystic lesion in posterior fossa with a hyperdense solid portion and multiple foci of calcifications (arrows in a). The lesion is infiltrating the occipital bone causing permeative destruction (arrows in b)

On MRI, a large extra-axial lesion (7.6 × 8.7 × 9.0 cm) was seen centred at the tentorium with cystic supratentorial and predominantly solid infratentorial components with significant compression on the cerebellum, brainstem, and fourth ventricle and hydrocephalus. The solid portion of the lesion was isointense with foci of hyperintensity on T1WIs (Fig. 2a), heterogeneously hypointense on T2WIs (Fig. 2b and c), and hyperintense on FLAIR. The mass had multiple blooming areas on SWIs (Fig. 2d) and heterogeneous areas of diffusion restriction on DWIs (Fig. 2e, f). Post-gadolinium T1-WIs showed heterogeneous post-contrast enhancement of the solid portion, with the peripheral and septal enhancement of the cystic portion (Fig. 2g, h).

Fig. 2

Axial T1-WI (a), axial T2-WI (b), and coronal T2-WI (c) show a large solid-cystic lesion in the posterior fossa with T1 (a) and T2 (b, c) isointense solid portion and multiloculated cystic components. Hyperintense foci (arrows in a) are seen, suggesting internal haemorrhage. Extensive areas of blooming on SWI (d) are seen, suggesting calcification and internal haemorrhage. The solid portion of the lesion is bright on DWI (e) with a corresponding signal loss on ADC (f), suggesting diffusion restriction. Axial (g) and coronal (h) post-gadolinium T1-WIs show heterogeneously enhanced solid portion and enhancement of the thick septations (g, h)

Right occipital craniotomy was done; the cyst was decompressed via the Omaya reservoir system. The tumour was found to be infratentorial; tentorium was incised to enter into the cyst with the tumour. The tumour was vascular, friable, dirty white with thrombosed vessels, and CUSA (cavitron ultrasonic surgical aspirator) suckable. A gross total excision was done, and the excised tumour was sent for histopathological examination.

Histopathological sections (Fig. 3a) showed diffuse sheets of small round tumour cells, a scant amount of cytoplasm, round to oval nuclei and stippled chromatin with inconspicuous nucleoli. The tumour cells showed diffuse immunopositivity for CD99 (strong membranous) and NKX2.2 (strong nuclear) on immunohistochemistry (Fig. 3b, c). The FISH assay was performed using an EWSR1 break-apart probe showed positivity for EWSR1 rearrangement and showed typical (1 fusion, 1 green, and 1 orange) and atypical (1 fusion & 1 green, 1 fusion & 1 orange) signal patterns (Fig. 3d). The histopathology, immunohistochemistry, and the FISH assay were confirmatory for Ewing’s sarcoma.

Fig. 3

H & E (×400) shows a malignant small round cell tumour with cells having scant cytoplasm, round to oval nuclei with finely stippled chromatin (a). Immunohistochemistry for CD99 shows strong membranous staining (b). Immunohistochemistry for NKX2.2 shows strong nuclear staining (c). EWSR1 break-apart FISH shows typical (1 fusion, 1 green and 1 orange) and atypical (1 fusion & 1 green, 1 fusion & 1 orange) signal pattern (d)

Discussion

Radiologic features of the intracranial ES are varied in different case reports. Most of them have described it as a heterogenous lobulated solid mass appearing hyperdense on CT, isointense on T1WIs and a hypointense signal on T2WIs with heterogenous post-contrast enhancement, calcification and haemorrhage [4, 10,11,12]. The large cystic component seen in our case has not been described. Most cases possibly arise from dura mater. Imaging differentials in an extra-axial lesion include metastatic tumours such as neuroblastoma, lymphoma, rhabdomyosarcoma, and primary tumours like meningeal sarcoma and solitary fibrous tumours [11]. These lesions can have a similar imaging appearance, but most have an associated extra-calvarial soft tissue component and significant bone destruction. If extra-axial versus intra-axial location remains a conundrum, differentials should include medulloblastoma, atypical teratoid/rhabdoid tumour, Embryonal tumour with multilayered rosettes, CNS tumour with BCOR internal tandem duplication, cribriform neuroepithelial tumour and CNS neuroblastoma, FOXR2-activated [11, 12].

Intracranial ES can be misdiagnosed as embryonal tumours like medulloblastoma, ATRT ( Atypical teratoid and rhabdoid tumour), or neuroblastoma due to the similarity in histologic appearance [12]. Recent advances in molecular testing have clarified these two entities. Molecular testing by RTPCR and FISH methods can depict ESR1 gene rearrangement which has high sensitivity and specificity in diagnosing ES [13]. Most common genetic aberration in ES is chromosomal translocation t(11,22) (q24; q12) followed by ESW/ERG t(21,22) (q22; q12). MIC2 gene (a pseudoautosomal gene) is commonly seen in ES [13, 14]. CD99, a cell surface glycoprotein (the gene product of MIC2), is essentially observed in all cases of ES on immunohistochemical staining [13, 14]. CNS embryonal tumours do not express MIC2 and are negative for CD99 [14]. The distinction between ES and embryonal tumours is important because their treatment is different, and they carry different prognoses. As a result of the latest advances in diagnosis and treatment, the outcome has significantly improved [15]. Intracranial ES requires surgery, chemotherapy, and field radiation therapy. Embryonal tumours also require surgery; however, chemotherapeutic and radiation protocols differ.

Conclusions

Radiologists should be aware of intracranial ES as a newly recognized entity. In our case, characteristic imaging findings were observed as similar to the PNET group, i.e. solid cystic, CT hypodensity, diffusion restriction, calcification and haemorrhage. The confirmative diagnosis of primary intracranial ES requires histological examination, immunohistochemical analysis, and genetic detection, combined with radiological findings.